Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database
Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database
复制标题
DOI：
10.1002/mds.23204
复制
发表时间：
2010-09-15
影响因子：
8.6
通讯作者：
Montastruc, Jean-Louis
中科院分区：
文献类型：
--
作者：
Perez-Lloret, Santiago;Bondon-Guitton, Emmanuelle;Montastruc, Jean-Louis
Pharmacodynamical differences between dopamine agonists (DAs) suggest differences in their adverse drug reactions (ADRs) profile. In this study, frequencies of ADR to DAs or levodopa reports in the French Pharmacovigilance Database were explored. Reports occurring between January 1, 1984 and December 31, 2008 were selected (2,189 for DAs and 1,315 for levodopa). The numbers of ADRs by system organ class were compared using ropinirole as a reference. Diurnal somnolence was less frequently reported with all DAs when compared with ropinirole (P < 0.001). Impulse control disorders (ICDs) were more frequently reported with pramipexole (P < 0.001). Significant difference was found among DAs in the frequency of confusion or disorientation < 0.001). No difference among DAs was observed in the frequency of hallucination or arterial hypotension ADR reports (P = 0.3 and P = 0.1). Pleural effusions were more frequently reported with pergolide or bromocriptine (P < 0.001). Somnolence or ICD reports were less frequent with levodopa, whereas confusion was more frequently reported. In summary, our data show significant differences in the kind of ADRs reported for each DA. (C) 2010 Movement Disorder Society
